Table 3.
Prevalence of MetS and its components in the XO quartile groups.
| Parameters | Serum XO | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | P-value | |
| Raised WC (%) | 11.6 | 23.2 | 12.7 | 15.8 | 0.335 |
| Elevated SBP (%) | 31.7 | 39.0 | 65.5 | 61.0 | 0.000 |
| Elevated DBP (%) | 42.7 | 43.9 | 46.4 | 46.3 | 0.952 |
| Elevated FBG (%) | 24.1 | 40.2 | 60.7 | 73.2 | 0.000 |
| Elevated TG (%) | 55.4 | 45.6 | 62.5 | 65.8 | 0.074 |
| Low HDL-C (%) | 92.8 | 79.1 | 73.0 | 85.1 | 0.021 |
| MetS (%) | 38.6 | 39.0 | 61.1 | 67.1 | 0.000 |
XO quartiles, Q1: ≤ 2.23 U/L, Q2: 2.24–3.72 U/L, Q3: 3.73–6.15 U/L, Q4: > 6.15 U/L. P-values are obtained from chi-square test.